Literature DB >> 31445062

Strategies to facilitate or block nose-to-brain drug delivery.

Patricia P Martins1, Hugh D C Smyth1, Zhengrong Cui2.   

Abstract

Nose-to-brain delivery has gained significant interest over the past several decades. This has resulted in numerous strategies described to improve the delivery of drugs to the brain directly through the olfactory epithelium of the nasal cavity. In some cases, intranasal administration may be more effective than other routes of administration in treating central nervous system and related disorders. Here, we briefly review the strategies that have been used to facilitate nose-to-brain delivery as well as approaches to block the delivery of drugs from the nose to the brain. Even though numerous strategies have already been used to increase nose-to-brain delivery, the research for strategies inhibitory of nose-to-brain delivery seems to be scarce.
Copyright © 2019 Elsevier B.V. All rights reserved.

Keywords:  Brain delivery; Devices; Intranasal; Local delivery; Systemic delivery

Mesh:

Substances:

Year:  2019        PMID: 31445062     DOI: 10.1016/j.ijpharm.2019.118635

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels.

Authors:  Sara Cunha; Ben Forbes; José Manuel Sousa Lobo; Ana Catarina Silva
Journal:  Int J Nanomedicine       Date:  2021-06-29

Review 2.  New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan.

Authors:  Roxana Popescu; Mihaela Violeta Ghica; Cristina-Elena Dinu-Pîrvu; Valentina Anuța; Dumitru Lupuliasa; Lăcrămioara Popa
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

3.  Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self-Healing Supramolecular Gel.

Authors:  Julie Tzu-Wen Wang; Ana C Rodrigo; Anna K Patterson; Kirsten Hawkins; Mazen M S Aly; Jia Sun; Khuloud T Al Jamal; David K Smith
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 17.521

4.  Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia.

Authors:  Xinxin Li; Shuling Li; Chun Ma; Tieshu Li; Lihua Yang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

5.  Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration.

Authors:  Siqi Wang; Yawen Yu; Aiping Wang; Xinliu Duan; Yuchen Sun; Liangxiao Wang; Liuxiang Chu; Yanan Lv; Nan Cui; Xuesong Fan; Chunjie Sha; Lixiao Xu; Kaoxiang Sun
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

6.  A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies.

Authors:  Laura Nižić Nodilo; Ivo Ugrina; Drago Špoljarić; Daniela Amidžić Klarić; Cvijeta Jakobušić Brala; Mirna Perkušić; Ivan Pepić; Jasmina Lovrić; Vesna Saršon; Maša Safundžić Kučuk; Dijana Zadravec; Livije Kalogjera; Anita Hafner
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

Review 7.  Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System.

Authors:  Tyler P Crowe; Walter H Hsu
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.